What is Eurax and how is it used?
Eurax is a prescription medicine used to treat the symptoms of Scabies and Pruritus. Eurax may be used alone or with other medications.
Eurax belongs to a class of drugs called Scabicidal Agent; Antipruritics/Non-corticosteroid Topical.
What are the possible side effects of Eurax?
Eurax may cause serious side effects including:
- difficulty breathing,
- swelling of your face, lips, tongue, or throat, and
- severe burning, stinging, or irritation after using this medicine
Get medical help right away, if you have any of the symptoms listed above.
The most common side effects of Eurax include:
- mild itching, and
- new rash
Tell the doctor if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Eurax. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
FOR TOPICAL USE ONLY
NOT FOR OPHTHALMIIC, ORAL, OR INTRAVAGINAL USE
Eurax (crotamiton USP) is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton USP, in a vanishing-cream or emollient-lotion base containing: water, petrolatum, propylene glycol, steareth-2, cetyl alcohol, dimethicone, laureth-23, fragrance, magnesium aluminum silicate, carbomer-934, sodium hydroxide, diazolidinylurea, methylchloroisothiazolinone, methylisothiazolinone and magnesium nitrate. In addition, the cream contains glyceryl stearate. Crotamiton is N-ethyl-N-(o-methylphenyl) -2-butenamide and its structural formula is:
Crotamiton USP is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol. Crotamiton is a mixture of the cis and trans isomers. Its molecular weight is 203.28.
DOSAGE AND ADMINISTRATION
In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Clothing and bed linen should be changed the next morning. A cleansing bath should be taken 48 hours after the last application.
In Pruritus: Massage gently into affected areas until medication is completely absorbed. Repeat as needed.
LOTION: Shake well before using.
DIRECTIONS FOR PATIENTS WITH SCABIES:
- Take a routine bath or shower. Thoroughly massage Eurax (crotamiton cream, lotion) cream or lotion into the skin from the chin to the toes including folds and creases.
- Put Eurax (crotamiton cream, lotion) cream or lotion under fingernails after trimming the fingernails short, because scabies are very likely to remain there. A toothbrush can be used to apply the Eurax (crotamiton cream, lotion) cream or lotion under the fingernails. Immediately after use, the toothbrush should be wrapped in paper and thrown away. Use of the same brush in the mouth could lead to poisoning.
- A second application is advisable 24 hours later.
- This 60 gram tube or bottle is sufficient for two applications.
- Clothing and bed linen should be changed the next day. Contaminated clothing and bed linen may be dry-cleaned, or washed in the hot cycle of the washing machine.
- A cleansing bath should be taken 48 hours after the last application.
Eurax (crotamiton USP)
Cream: 60g tubes (NDC 0072-2103-60; NSN 6505-00-116-0200).
Lotion: 60g (2 oz.) bottles (NDC 0072-2203-60, NSN 6505-01-153- 4423).
454g (16 oz.) bottles (NDC 0072-2203-16).
SHAKE WELL before using.
Store at room temperature.
Keep out of reach of children.
Westwood-Squibb Pharmaceuticals, Inc. A Bristol-Myers Squibb Company, Princeton, NJ 08543, USA. FDA Rev date: 6/26/2003
If severe irritation or sensitization develops, treatment with this product should be discontinued and appropriate therapy instituted.
Eurax (crotamiton cream, lotion) should not be applied in the eyes or mouth because it may cause irritation. It should not be applied to acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term carcinogenicity studies in animals have not been conducted.
Pregnancy (Category C)
Animal reproduction studies have not been conducted with Eurax (crotamiton cream, lotion) . It is also not known whether Eurax (crotamiton cream, lotion) can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. Eurax (crotamiton cream, lotion) should be given to a pregnant woman only if clearly needed.
Safety and effectiveness in children have not been established.
Clinical studies with Eurax (crotamiton USP) Lotion/Cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
There is no specific information on the effect of overtreatment with repeated topical applications in humans. A death was reported but cause was not confirmed.
Accidental oral ingestion may be accompanied by burning sensation in the mouth, irritation of the buccal, esophageal and gastric mucosa, nausea, vomiting, abdominal pain.
If accidental ingestion occurs, call your Poison Control Center.
Eurax (crotamiton cream, lotion) should not be applied topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.
Skin Problems and Treatments Resources
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Health Solutions From Our Sponsors